Related Experiment Videos
Critical pulmonary stenosis.
1Department of Pediatric Cardiology, Center for Pediatric and Congenital Heart Diseases, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Journal of Interventional Cardiology
|June 11, 2002
Summary
Critical pulmonary stenosis in neonates is treated with prostaglandin E1 and balloon valvuloplasty. While initial cyanosis may persist, long-term outcomes for this critical heart defect are generally excellent.
Area of Science:
- Pediatric Cardiology
- Neonatal Critical Care
- Interventional Cardiology
Background:
- Critical pulmonary stenosis is a life-threatening neonatal condition causing cyanosis.
- Early management involves resuscitation and prostaglandin E1 to maintain ductal patency.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for neonates with critical pulmonary stenosis.
- To review the immediate and long-term outcomes of balloon valvuloplasty for this condition.
Main Methods:
- Diagnosis typically relies on echocardiography, with right ventriculography used in select cases.
- Intervention involves balloon valvuloplasty, sizing the balloon to 1.2 times the annulus diameter.
- Catheter techniques and guidewire passage are crucial for successful intervention.
Main Results:
- Immediate post-procedure cyanosis is common but usually resolves with right ventricular adaptation.
- Excellent intermediate-to-long-term results are observed, with a low need for reoperation (5-10%).
- Pulmonary insufficiency is a long-term concern, and up to 30% may require repeat procedures.
Conclusions:
- Balloon valvuloplasty is an effective treatment for critical pulmonary stenosis in neonates.
- Long-term follow-up is essential to monitor for pulmonary insufficiency and the need for repeat interventions.